Elevated transferrin receptor impairs T cell metabolism and function in systemic lupus erythematosus
PANEERSELVAL C
GLP-1 is released after eating, stimulating insulin secretion, suppressing glucagon, slowing gastric emptying, and promoting satiety
Originally used to treat type 2 diabetes, GLP-1 drugs have recently become popular to assist in weight loss, either through off-label use or, in specific cases, as an One such GLP-1 medication is In addition to use for the treatment of type 2 diabetes and obesity, previous research has also looked at using liraglutide to treat other conditions including polycystic ovary syndrome (PCOS), Now researchers from Imperial College London, in the United Kingdom, recently presented research at the Alzheimers Association International Conference 2024 reporting that liraglutide may also help protect the brain from developing Alzheimers disease by reducing Their study has not yet appeared in a peer-reviewed journal
To be or not to be gastric emptying and GLP-1
In vitro antioxidant and free radical scavenging activity of Cyperus rotundus